General Information of Drug (ID: DMJQ7XD)

Drug Name
Recombinant TSH superagonists Drug Info
Synonyms
Recombinant TSH superagonists (thyroid cancer); TR-1401; TR-1402; Recombinant TSH superagonists (thyroid cancer), Trophogen; TSH superagonist (thyroid cancer/goiter), Trophogen; Thyroid stimulating hormone superagonist (thyroid cancer/goiter), Trophogen
Indication
Disease Entry ICD 11 Status REF
Thyroid cancer 2D10 Investigative [1]
Cross-matching ID
TTD Drug ID
DMJQ7XD

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug(s) Targeting Thyrotropin receptor (TSHR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Thyrotropin DMJ47QC Hypothyroidism 5A00 Approved [2]
Thyrotropin Alfa DMMYLTI Thyroid cancer 2D10 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Thyrotropin receptor (TSHR) TT6NYJA TSHR_HUMAN Agonist [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 255).
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3 Pharmacological profiles and clinical effects of recombinant human thyrotropin alfa (Thyrogen) Intramuscular Injection 0.9 mg). Nippon Yakurigaku Zasshi. 2009 Jul;134(1):28-34.